Fundz

OneCell Diagnostics raised $16 million in a Series A funding round led by Celesta Capital to advance their precision oncology liquid biopsy diagnostics.

PRIVATENov 21, 2024

Amount Raised

$16 Million

Round Type

Series A

PuneBiotechnologyHealth CareArtificial IntelligenceMedicalHealth Diagnostics

Investors

Cedars SinaiTenacity VenturesEragonSingularity VenturesCelesta Capital

Description

OneCell Diagnostics, an AI-powered cancer diagnostics startup, raised $16 million in an oversubscribed Series A funding round. The funding will be used to democratize precision oncology through accessible cancer testing and to expand into the US market with their next-generation liquid biopsy test, OncoIndx Alfa.

Quick answer

OneCell Diagnostics raised $16 Million in a Series A round, dated November 21, 2024. Investors: Cedars Sinai, Tenacity Ventures, Eragon, Singularity Ventures and Celesta Capital. OneCell Diagnostics is based in Pune, Maharashtra, India.

How much did OneCell Diagnostics raise?
OneCell Diagnostics raised $16 Million in a Series A round on November 21, 2024.
Who invested in OneCell Diagnostics?
Cedars Sinai, Tenacity Ventures, Eragon, Singularity Ventures and Celesta Capital are named as investors in this round.
What does OneCell Diagnostics do?
OneCell Diagnostics, Inc. is a Precision Oncology Liquid Biopsy Diagnostics Company focused on developing the 1st-in-Class, Circulating Tumor Cell (CTC)-based, Single-Cell Multi-omics Lab Developed Tests for..
Where is OneCell Diagnostics based and how big is it?
OneCell Diagnostics is based in Pune, Maharashtra, India. Fundz records about 87 employees.
Who are the decision-makers at OneCell Diagnostics?
Fundz holds 4 contacts at OneCell Diagnostics. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Medical and Health Diagnostics around the same time

Companies in the same sectors as OneCell Diagnostics that raised within 45 days of this round, from Fundz verified event records.

  • Chiron Health AI raised an undisclosed amount (Pre-Seed) on November 22, 2024.
  • Ligence raised $3.2M (Seed) on November 13, 2024.
  • Definition Health raised $7.4M (Pre-Seed) on October 31, 2024.
  • Vara raised $8.9M (Funding Round) on October 29, 2024.
  • Pharos raised $5M (Seed) on October 25, 2024.
  • Carna raised $3.4M (Seed) on January 3, 2025.

Who to call at OneCell Diagnostics, and when

A new round usually means OneCell Diagnostics is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day OneCell Diagnostics raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at OneCell Diagnostics, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at OneCell Diagnostics. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

OneCell Diagnostics

Location

Pune, Maharashtra, India

About

OneCell Diagnostics, Inc. is a Precision Oncology Liquid Biopsy Diagnostics Company focused on developing the 1st-in-Class, Circulating Tumor Cell (CTC)-based, Single-Cell Multi-omics Lab Developed Tests for applications in clinical cancer care & early-stage clinical trials for Biotech/Pharma companies. ​ OneCell Diagnostics, Inc. is a joint venture between two companies with innovative technologies: Actorius Innovations and Research Pvt Ltd, a leading provider of CTC Tests in India, and Indx.ai, a Silicon Valley based innovative software company specialising in Multi-omics Biomarker Data Analytics.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment OneCell Diagnostics raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

4 contacts
Predictive Intelligence
Strategic

ML-powered predictions for OneCell Diagnostics's next move

See what Strategic adds

Funding Insights

What this usually means
Typical timeline to Series B
Series A companies typically raise their next round in 10-18 months

OneCell Diagnostics raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.